…
PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. It offers prescription drug and custom compounding specialization services; weight loss and lifestyle management solutions, including health and wellness products; and convenience and confectionary products. The company was incorporated in 2021 and is headquartered in Saskatoon, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
PharmaCorp Rx Inc. is a publicly listed company on the TSX Venture Exchange (PCRX.V); public disclosures are limited and operational details are sparse. Future growth would depend on product development progress, regulatory approvals and successful commercialization, which could support revenue if achieved. Investors may find potential upside from milestone-driven value creation but should rely on company filings for specifics.
Principal risks include binary regulatory and clinical outcomes, likely financing and liquidity constraints typical of small-cap pharmaceutical issuers, and competitive and execution risks.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 |
| Income before tax | -1.16M | -0.47M | -0.52M |
| Net income | -1.05M | -0.47M | -0.52M |
| Selling general administrative | 3.48M | 0.58M | 0.56M |
| Gross profit | 2.18M | 0.00M | - |
| Reconciled depreciation | 0.29M | 0.00M | - |
| Operating income | -1.59M | -0.58M | -0.56M |
| Interest expense | 0.03M | 0.00M | - |
| Tax provision | -0.11M | 0.00M | - |
| Interest income | 0.38M | 0.11M | 0.05M |
| Net interest income | 0.35M | 0.11M | 0.05M |
| Total revenue | 5.79M | 0.00M | 0.00M |
| Total operating expenses | 7.38M | 0.58M | 0.56M |
| Cost of revenue | 3.61M | 0.00M | - |
| Total other income expense net | 0.08M | - | - |
| Net income from continuing ops | -1.05M | -0.47M | -0.52M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 35.21M | 2.32M | 2.73M | 1.00M |
| Intangible assets | 5.13M | - | - | - |
| Total liab | 4.64M | 0.05M | 0.02M | 0.03M |
| Total stockholder equity | 30.34M | 2.27M | 2.72M | 0.97M |
| Capital stock | 31.70M | 2.80M | 2.74M | 1.00M |
| Retained earnings | -2.03M | -1.01M | -0.54M | -0.03M |
| Good will | 11.48M | 0.00M | - | - |
| Cash | 12.89M | 2.24M | 2.73M | 0.98M |
| Total current liabilities | 1.70M | 0.05M | 0.02M | 0.03M |
| Short long term debt | 0.08M | - | - | - |
| Total current assets | 14.57M | 2.32M | 2.73M | 1.00M |
| Net receivables | 0.33M | 0.00M | - | - |
| Long term debt | 0.32M | - | - | - |
| Inventory | 1.31M | 0.00M | - | - |
| Accounts payable | 1.54M | 0.05M | 0.02M | 0.03M |
| Non current assets total | 20.63M | 0.00M | 0.00M | 0.00M |
| Capital lease obligations | 0.56M | 0.00M | - | - |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 |
| Investments | -16.86M | 0.00M | - |
| Total cash from financing activities | 27.38M | 0.03M | 1.87M |
| Net income | -1.05M | -0.47M | -0.52M |
| Change in cash | 10.64M | -0.49M | 1.75M |
| Begin period cash flow | 2.24M | 2.73M | 0.98M |
| End period cash flow | 12.89M | 2.24M | 2.73M |
| Total cash from operating activities | 0.12M | -0.52M | -0.12M |
| Issuance of capital stock | 27.33M | 0.03M | 2.00M |
| Depreciation | 0.29M | 0.00M | - |
| Dividends paid | - | - | 0.00M |
| Capital expenditures | 0.01M | 0.00M | 0.00M |
| Change in working capital | 0.71M | -0.05M | 0.01M |
| Stock based compensation | 0.28M | 0.00M | 0.39M |
| Other non cash items | 0.03M | - | - |
| Free cash flow | 0.12M | -0.52M | -0.12M |
Sector: Healthcare Industry: Pharmaceutical Retailers
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PCRX PharmaCorp Rx Inc. |
-0.01 1.22% |
0.41 | 20.50 | 41.49 | 2.78 | 1.65 | 2.77 | 41.56 |
| HITI High Tide Inc |
-0.04 1.02% |
3.88 | - | 45.05 | 0.46 | 3.36 | 0.65 | 10.91 |
PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. It offers prescription drug and custom compounding specialization services; weight loss and lifestyle management solutions, including health and wellness products; and convenience and confectionary products. The company was incorporated in 2021 and is headquartered in Saskatoon, Canada.
303 Wellman Lane, Saskatoon, SK, Canada, S7T 0J1
| Name | Title | Year Born |
|---|---|---|
| Mr. Alan A. Simpson | Executive Chairperson | 1958 |
| Mr. Grady Brown | CEO & Director | NA |
| Mr. Calvin LeRoux | President & Director | NA |
| Ms. Terri Jean Tatchell | Chief Financial Officer | NA |
| Mr. Paul Dale | Chief Operating Officer | NA |
| Ms. Kimberly Carroll | Corporate Secretary | NA |
| Mr. Paul Dale | President & COO | NA |
| Mr. Calvin LeRoux | Strategic Advisor to CEO & Director | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.